• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    United Therapeutic (NQ: UTHR )

    373.97 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about United Therapeutic

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Earnings Scheduled For May 4, 2022
    Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million. 
    Via Benzinga
    Earnings Outlook For United Therapeutics
    United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that United... 
    Via Benzinga
    United Therapeutics Q1 2022 Earnings Conference Call On May 4, 2022 At 09:00 AM ET
    United Therapeutics (NASDAQ:UTHR) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend United Therapeutics (UTHR) Conference Call Follow this... 
    Via Benzinga
    United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference
    From United Therapeutics Corporation
    Via Business Wire
    United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022
    From United Therapeutics Corporation
    Via Business Wire
    United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
    From United Therapeutics Corporation
    Via Business Wire
    First Human With Pig Heart Transplant Dies: Reuters
    A 57-year-old man with terminal heart disease who became the first person to receive a genetically modified pig's heart has died, the University of Maryland Medical... 
    Via Benzinga
    10 Biggest Price Target Changes For Monday
    Barclays cut the price target on MasTec, Inc. (NYSE: MTZ) from $140 to $120. MasTec shares fell 0.1% to $79.00 in pre-market trading. 
    Via Benzinga
    Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease
    PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world 
    Via Newswire.com
    United Therapeutics Earnings Perspective: Return On Capital Employed
    Pulled from Benzinga Pro data, United Therapeutics (NASDAQ:UTHR) posted Q4 earnings of $112.20 million, an increase from Q3 of 31.04%. Sales dropped to $415.20 million, a 6.63%... 
    Via Benzinga
    FDA Pushes United Therapeutics-MannKind Tyvaso DPI's Decision Date; United Therapeutics' Q4 Misses Consensus
    United Therapeutics Corp (NASDAQ: UTHR) and its partner MannKind Corp (NASDAQ: MNKD) have received an FDA information request letter for additional... 
    Via Benzinga
    United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
    From United Therapeutics Corporation
    Via Business Wire
    United Therapeutics's Earnings Outlook
    United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022
    From United Therapeutics Corporation
    Via Business Wire
    United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs
    From United Therapeutics Corporation
    Via Business Wire
    First Successful Pig Heart Transplant Into Human: Details On The Amazing Technology And A Public Company To Watch
    Pigs may not be able to fly, but they've provided a vital organ in a life-saving surgery for one U.S. man. What Happened: A Maryland hospital completed the first... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is... 
    Via Benzinga
    7 Pharmaceutical Stocks That Could Make You Rich
    Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich 
    Via InvestorPlace
    Mark To Market
    I thought that I would have a look at my own financial performance in 2021. In preview, I did alright, but not as well as the market. Let's take a look at what my portfolio held and how well it did. 
    Via Talk Markets
    United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst
    From United Therapeutics Corporation
    Via Business Wire
    United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022
    From United Therapeutics Corporation
    Via Business Wire
    Liquidia's Inhaled Treprostinil Powder Scores Tentative FDA Approval For PAH
    The FDA has granted tentative approval to Liquidia Corporation's (NASDAQ: LQDA) Yutrepia (treprostinil) inhalation powder for pulmonary arterial... 
    Via Benzinga
    Exposures Product Safety
    United Therapeutics Corporation (UTHR) Q3 2021 Earnings Call Transcript
    UTHR earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
    Via Benzinga
    Topics Retirement
    Exposures Pension
    Recap: United Therapeutics Q3 Earnings
    United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the announcement... 
    Via Benzinga
    Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
    The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a... 
    Via Benzinga
    Why Shares of MannKind Corporation Are Falling This Morning
    Investors are hyperventilating after a delay for its inhaled medicine. 
    Via The Motley Fool
    FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
    The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary... 
    Via Benzinga
    Exposures Product Safety
    Earnings Scheduled For November 3, 2021
    Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.